bud22 Antibody

What is BUD22 and what are its known functions in different organisms?

BUD22 was originally discovered in yeast during a systematic screen of homozygous diploid yeast deletion mutants with altered budding patterns. In Saccharomyces cerevisiae, BUD22 plays crucial roles in ribosome biogenesis, particularly in 18S rRNA processing and 40S subunit formation. It also influences polysome density and affects the +1 translational frameshifting event required for certain protein expressions .

In humans, BUD22 is also known as serum response factor binding protein 1 (SRFBP1), P49, Rlb1, or STRAP. The protein has been implicated in transcriptional regulation through interaction with serum response factor .

For experimental design, researchers should consider these organism-specific functions when interpreting their results:

What types of BUD22 antibodies are available for research purposes?

Currently, the primary BUD22 antibodies available for research are polyclonal antibodies raised in rabbits. Based on available information, these include:

• Rabbit anti-Saccharomyces cerevisiae BUD22 polyclonal antibody - Specifically recognizes BUD22 from baker's yeast, applicable for ELISA and Western Blot applications .

• Rabbit anti-Schizosaccharomyces pombe BUD22 polyclonal antibody - Targets BUD22 (SPAC4F10.06) from fission yeast, suitable for ELISA and Western Blot applications .

• Rabbit anti-human SRFBP1 polyclonal antibody - Recognizes the human homolog (also annotated as BUD22/P49/STRAP), validated for ELISA and immunohistochemistry applications .

When selecting antibodies, researchers should verify the target species specificity and validated applications to ensure experimental success.

How can I optimize Western blot protocols for BUD22 detection?

For effective Western blot detection of BUD22, consider these methodological recommendations based on published research approaches:

• Sample preparation: Total cell protein isolation methods similar to those described by Atkin et al. are recommended . Use approximately 50 μg of total protein per lane for adequate detection.

• Transfer and blotting conditions: For optimal results, use PVDF membranes and follow these parameters:

  • Transfer at 100V for 1 hour in 25mM Tris, 192mM glycine buffer with 20% methanol

  • Block with 5% non-fat milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature

  • Incubate with primary anti-BUD22 antibody (1:1000 dilution) overnight at 4°C

  • Detect using HRP-linked secondary antibodies and chemiluminescence systems

• Controls: Include both positive controls (wild-type expressing BUD22) and negative controls (bud22Δ mutants if working with yeast) .

What experimental approaches can help investigate BUD22's role in ribosome biogenesis?

BUD22's involvement in ribosome biogenesis can be studied through multiple complementary approaches:

A comprehensive experimental design would include all three approaches to provide corroborating evidence of BUD22's specific role in the ribosome biogenesis pathway.

How can I design experiments to investigate BUD22's impact on translational frameshifting?

The role of BUD22 in +1 translational frameshifting, particularly in the context of Ty1 retrotransposition in yeast, can be investigated through these methodological approaches:

• Frameshifting reporter assays: Construct dual-luciferase reporters containing the Ty1 frameshifting sequence between Renilla and firefly luciferase genes. Compare frameshifting efficiency in wild-type and bud22Δ strains by measuring the ratio of firefly to Renilla luciferase activity.

• Analysis of Gag processing: Western blot analysis of Ty1 Gag processing provides a direct measurement of frameshifting effects. In previous studies, bud22Δ showed defects in Gag processing, with incomplete conversion of Gag-p49 to the mature p45 form . This approach requires:

  • Isolation of virus-like particles (VLPs)

  • Western blotting using anti-Gag antibodies

  • Quantification of p49:p45 ratios as indicators of frameshifting efficiency

• Ribosome occupancy profiling: Use ribosome profiling techniques to analyze ribosome positioning at frameshifting sites in wild-type versus bud22Δ strains, providing mechanistic insights into how BUD22 affects ribosome behavior at these specific mRNA regions.

These methods should be used in combination to establish a causal relationship between BUD22 function and +1 frameshifting events.

What approaches can resolve apparent contradictions in BUD22 localization data?

Researchers may encounter conflicting data regarding BUD22 localization, as it has been reported in different cellular compartments. To resolve such contradictions:

• Multi-method localization analysis: Compare results from:

  • Fluorescently tagged BUD22 (GFP/RFP fusion proteins)

  • Indirect immunofluorescence using anti-BUD22 antibodies

  • Subcellular fractionation followed by Western blotting

• Dynamic localization studies: Track BUD22 localization under different physiological conditions and cell cycle stages, as localization may change in response to cellular state. Previous research suggests associations with both nuclear and nucleolar structures .

• Validation with multiple antibodies or tags: Use antibodies targeting different epitopes or various tagging strategies to rule out artifacts from a specific detection method.

• Co-localization with known markers: Perform co-localization experiments with established nuclear, nucleolar, and cytoplasmic markers to precisely define BUD22's distribution pattern.

The consensus from available data suggests that Bud22p is present in the nucleus and nucleolus in yeast, consistent with its role in ribosome biogenesis .

How can I address specificity issues with BUD22 antibodies?

When encountering specificity concerns with BUD22 antibodies:

• Validation controls:

  • Use genetic knockouts (bud22Δ) as negative controls

  • Test pre-immune serum to identify non-specific binding

  • Perform peptide competition assays to confirm epitope specificity

• Cross-reactivity analysis: If working with human SRFBP1/BUD22, be aware that the gene has multiple aliases (P49, Rlb1, STRAP) and may cross-react with related proteins . Western blots should be carefully analyzed for bands at unexpected molecular weights.

• Optimization strategies for improved specificity:

  • Increase antibody dilution (1:2000-1:5000) to reduce background

  • Extend blocking time to 2 hours with 5% BSA instead of milk

  • Include 0.1-0.2% SDS in antibody dilution buffer to reduce non-specific binding

How should I interpret changes in BUD22 expression patterns in response to cellular stress?

BUD22's involvement in fundamental cellular processes like ribosome biogenesis suggests its expression may change during stress responses. When analyzing such changes:

• Comprehensive expression analysis: Compare BUD22 protein levels (via Western blot) with mRNA expression (via RT-qPCR) to determine if changes occur at transcriptional or post-transcriptional levels.

• Correlation with stress markers: Analyze BUD22 expression alongside established stress response markers for proper interpretation. Relevant stress pathways include:

  • Nutrient deprivation responses

  • Unfolded protein response (UPR)

  • Environmental stress response (ESR) genes

• Temporal analysis: Determine whether BUD22 expression changes are early or late events in stress response by sampling at multiple time points after stress induction.

• Functional implications: Connect expression changes to functional outcomes by simultaneously assessing ribosome biogenesis markers, such as pre-rRNA processing intermediates and polysome profiles .

How can BUD22 antibodies be used to study the relationship between ribosome biogenesis and cell growth regulation?

BUD22's dual role in ribosome biogenesis and budding pattern regulation makes it an interesting target for studying growth control:

• Co-immunoprecipitation studies: Use BUD22 antibodies to identify interaction partners that might connect ribosome biogenesis to cell cycle progression. Suggested protocol:

  • Cross-link cells with 1% formaldehyde for 10 minutes

  • Prepare cell lysates under non-denaturing conditions

  • Immunoprecipitate with anti-BUD22 antibodies

  • Analyze precipitated proteins by mass spectrometry

• Phenotypic correlation analysis: Quantify the relationship between BUD22 expression levels, ribosome biogenesis defects (measured by rRNA processing), and growth parameters (measured by budding pattern and cell size).

• Conditional expression systems: Design experiments using regulatable BUD22 expression to determine the threshold levels required for normal ribosome biogenesis versus normal budding patterns.

BUD22 was originally identified in a screen for budding pattern defects, and subsequent research has connected it to ribosome biogenesis pathways, suggesting an important link between these cellular processes .